Silverarc Capital Management, LLC Ardelyx, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.27 - $8.17 $126,030 - $810,766
-99,237 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$6.55 - $8.98 $355,252 - $487,048
54,237 Added 120.53%
99,237 $752,000
Q1 2021

May 18, 2021
SELL
$6.1 - $7.69 $457,500 - $576,750
-75,000 Reduced 62.5%
45,000 $298,000
Q4 2020

Feb 16, 2021
BUY
$5.05 - $7.1 $606,000 - $852,000
120,000 New
120,000 $776,000

Others Institutions Holding ARDX

# of Institutions
213
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $775M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email